Kohei Shiroshita

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (38)

• Developmental Cues and Stage‑Matched Niches for Engineering Engraftable Human HSCs
  Experimental Hematology 2026 DOI: 10.1016/j.exphem.2026.105958
  +Save
• Unlocking the curative potential of gene transfer and editing for hematopoietic disorders
  Experimental Hematology 2026 DOI: 10.1016/j.exphem.2026.105493
  +Save
• The rise of bone marrow organoids as next-generation models for blood formation and failure
  Experimental Hematology 2026 DOI: 10.1016/j.exphem.2026.105428
  +Save
• Risks and Benefits of Obinutuzumab-based Chemotherapy in the Context of SARS-CoV-2 Infection
  INTERNAL MEDICINE 2026 DOI: 10.2169/INTERNALMEDICINE.5962-25
  +Save
• Decreased non-neurogenic acetylcholine in bone marrow triggers age-related defective stem/progenitor cell homing
  Nature Communications 2025 DOI: 10.1038/s41467-025-60515-9
  +Save
• Biallelic TEDC1 variants cause a new syndrome with severe growth impairment and endocrine complications
  European Journal of Human Genetics 2025 DOI: 10.1038/s41431-025-01802-3
  +Save
• CATHEPSIN F PROMOTES RETURN TO QUIESCENCE OF HEMATOPOIETIC STEM CELLS
  EXPERIMENTAL HEMATOLOGY 2025
  +Save
• Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack
  FRONTIERS IN IMMUNOLOGY 2025 DOI: 10.3389/FIMMU.2025.1635943
  +Save
• Prophylaxis Against Central Nervous System Relapse in Methotrexate-associated Intravascular Large B-cell Lymphoma
  INTERNAL MEDICINE 2025 DOI: 10.2169/INTERNALMEDICINE.4692-24
  +Save
• Unexpected progression of lymphoplasmacytic lymphoma with TP53 deletion after treatment for concurrent multiple myeloma with IGH::CCND1
  LEUKEMIA & LYMPHOMA 2025 DOI: 10.1080/10428194.2025.2536126
  +Save
• Aberrant CD4 expression in plasmablastic transformation of multiple myeloma
  EJHAEM 2024 DOI: 10.1002/JHA2.935
  +Save
• Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy
  JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY 2024 DOI: 10.3960/JSLRT.24024
  +Save
• Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis
  S. Watanuki, Hiroshi Kobayashi, Yuki Sugiura +25 more
  ELIFE 2024 DOI: 10.7554/ELIFE.87674
  +Save
• Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis (vol 12, RP87674, 2024)
  ELIFE 2024 DOI: 10.7554/ELIFE.104576
  +Save
• Daratumumab improved severe neutrophilia and paraneoplastic bone marrow fibrosis in granulocyte-colony stimulating factor-producing multiple myeloma
  EJHAEM 2024 DOI: 10.1002/JHA2.901
  +Save
• Does R-EPOCH reduce the incidence of pulmonary embolism in cardiac lymphoma?
  ANNALS OF HEMATOLOGY 2024 DOI: 10.1007/S00277-024-05872-Z
  +Save
• Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood
  ANNALS OF HEMATOLOGY 2024 DOI: 10.1007/S00277-024-06123-X
  +Save
• SDHAF1 confers metabolic resilience to aging hematopoietic stem cells by promoting mitochondrial ATP production
  CELL STEM CELL 2024 DOI: 10.1016/J.STEM.2024.04.023
  +Save
• Thromboembolism Early After Glucocorticoid Administration in Patients with Autoimmune Hemolytic Anemia
  Clinical Hematology International 2023 DOI: 10.1007/s44228-023-00043-9
  +Save
• Context-Dependent Modification of PFKFB3 in Hematopoietic Stem Cells Promotes Anaerobic Glycolysis and Ensures Stress Hematopoiesis
  bioRxiv 2023 DOI: 10.1101/2023.03.16.532898
  +Save